Watch for near-term cash runway update and potential alternative financing arrangement (debt or equity). The termination removes future dilution from this specific deal but also removes a $1M capital line, increasing liquidity pressure for a micro-cap with a $20M market cap.
Price Chart
Executive Summary
Firefly Neuroscience and an investor mutually terminated a securities purchase agreement on June 25, 2026, which had been entered into on May 6, 2026, to sell up to 666,667 units at $1.50 per unit for aggregate gross proceeds of up to $1,000,000. The cancellation eliminates a dilutive equity raise but also removes a planned cash infusion of up to $1M for the $20M market-cap company, creating a financing gap that raises going-concern risk.
Key Facts
- Agreement dated May 6, 2026 for up to 666,667 units at $1.50/unit was mutually terminated on June 25, 2026
- Aggregate gross proceeds of up to $1,000,000 from the purchase agreement are now forfeited
- No termination fees or penalties mentioned; termination was mutual under Section 5.3 of the agreement
- Company market cap ~$20M; $1M represents ~5% of market cap in lost potential financing
Financial Impact
Loss of up to $1,000,000 in gross proceeds that were expected to be raised; no break fee or penalty payments disclosed
Risk Factors
- Cash position and liquidity concerns — lost $1M financing raises risk of needing more onerous terms elsewhere
- Potential for debt or convertible issuance on less favorable terms to replace the terminated equity line
- No replacement financing announced; extended cash burn without new capital could trigger going-concern disclosure
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-072645 |
| Document: 0001213900-26-072645-index-headers.html | 0001213900-26-072645 |
| Document: 0001213900-26-072645-index.html | 0001213900-26-072645 |
| Document: 0001213900-26-072645.txt | 0001213900-26-072645 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 25, 2026 4w ago | Press Release | $2.01 $0.9196 | ▼ −54.25% | ▼ −52.77% | $0.9400 (−53.23%) |
Sep 17, 2026 5w ago | Press Release | $1.28 $1.10 | ▼ −14.06% | ▼ −15.52% | $0.9400 (−26.56%) |
Jul 1, 2026 16w ago | EFFECT | $1.29 $1.07 | ▲ +17.05% | ▲ +14.87% | $0.9400 (+27.13%) |
Jun 26, 2026 17w ago | 8-K | $1.23 $1.11 | ▲ +9.76% | ▲ +9.48% | $0.9400 (+23.58%) |
Jun 23, 2026 17w ago | S-3/A | $1.19 $1.13 | ▲ +5.04% | ▲ +6.97% | $0.9400 (+21.01%) |
Jun 22, 2026 18w ago | 8-K | $1.31 $1.12 | ▼ −14.50% | ▼ −15.66% | $0.9400 (−28.24%) |
May 12, 2026 23w ago | 8-K | $1.80 $1.61 | ▲ +10.56% | ▲ +9.94% | $0.9400 (+47.78%) |
Apr 22, 2026 26w ago | 8-K | $2.06 $1.68 | ▼ −18.45% | ▼ −23.08% | $0.9400 (−54.37%) |
Mar 26, 2026 30w ago | Press Release | $3.02 $2.29 | ▼ −24.17% | ▼ −34.84% | $0.9400 (−68.87%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers